PGE2 in the Regulation of Programmed Erythrocyte Death

Total Page:16

File Type:pdf, Size:1020Kb

PGE2 in the Regulation of Programmed Erythrocyte Death Cell Death and Differentiation (2005) 12, 415–428 & 2005 Nature Publishing Group All rights reserved 1350-9047/05 $30.00 www.nature.com/cdd PGE2 in the regulation of programmed erythrocyte death PA Lang1, DS Kempe1, S Myssina1, V Tanneur1, C Birka1, phosphate-buffered saline; FITC, fluorescein isothiocyanate; S Laufer2, F Lang*,1, T Wieder1 and SM Huber1 WGA, Triticum vulgare lectin; FSC, forward scatter; SSC, sideward scatter; PMSF, phenylmethylsulfonyl fluoride; SDS, 1 Department of Physiology, University of Tu¨bingen, Germany sodium dodecylsulfate; BSA, bovine serum albumin; SDS-PAGE, 2 Institute of Pharmacy, University of Tu¨bingen, Germany sodiumdodecylsulfate polyacrylamide gel electrophoresis; ECL, * Corresponding author: F Lang, Physiologisches Institut der Universita¨t enhanced chemiluminescence Tu¨bingen, Gmelinstr. 5, D-72076 Tu¨bingen, Germany. Tel: þ 49 7071 29 72194; Fax: þ 49 7071 29 5618; E-mail: fl[email protected] Received 05.4.04; revised 15.11.04; accepted 23.11.04; published online 04.3.05 Edited by M Piacentini Introduction Until recently, erythrocytes have been considered unable Abstract to undergo apoptosis, as they lack mitochondria and nuclei, key organelles in the apoptotic machinery of nucleated Hyperosmotic shock, energy depletion, or removal of 1 extracellular ClÀ activates Ca2 þ -permeable cation channels cells. However, most recent observations revealed that treatment of erythrocytes with the Ca2 þ -ionophore ionomycin in erythrocyte membranes. Subsequent Ca2 þ entry induces leads to cell shrinkage, cell membrane blebbing and erythrocyte shrinkage and exposure of phosphatidylserine annexin binding,2–7 all typical features of apoptosis in (PS) at the erythrocyte surface. PS-exposing cells are other cell types.1,8 The breakdown of phosphatidylserine engulfed by macrophages. The present study explored the asymmetry results from the activation of a scramblase À signalling involved. Hyperosmotic shock and Cl removal which is activated by increase of cytosolic Ca2 þ activity.9,10 triggered the release of prostaglandin E2 (PGE2). In whole-cell As macrophages are equipped with receptors specific recording, activation of the cation channels by ClÀ removal for phosphatidylserine,11–13 erythrocytes exposing phospha- was abolished by the cyclooxygenase inhibitor diclophenac. tidylserine at their surface will be rapidly recognized, 14–16 In FACS analysis, phospholipase-A inhibitors quinacrine and engulfed and degraded. Thus, an increase of cytosolic 2 2 þ palmitoyltrifluoromethyl-ketone, and cyclooxygenase inhibi- Ca activity could trigger apoptotic death and clearance tors acetylsalicylic acid and diclophenac, blunted the of erythrocytes. Ca2 þ entry further activates Ca2 þ -sensitive K þ chan- increase of PS exposure following ClÀ removal. PGE (but 2 nels,17,18 leading to or augmenting cell shrinkage.19 Ca2 þ not thromboxane) induced cation channel activation, increase 2 þ 2 þ may enter erythrocytes through Ca -permeable cation in cytosolic Ca concentration, cell shrinkage, PS exposure, channels,20,21 which are activated following removal of calpain activation, and ankyrin-R degradation. The latter was external ClÀ, osmotic shock by increase of extracellular attenuated by calpain inhibitors-I/II, while PGE2-induced PS osmolarity, oxidative stress by addition of t-butylhydroper- exposure was not. In conclusion, hyperosmotic shock or ClÀ oxide (t-BHP) and energy depletion by removal of extracellular 5,6 removal stimulates erythrocyte PS exposure through PGE2 glucose. Activation of those channels triggers breakdown of formation and subsequent activation of Ca2+-permeable phosphatidylserine asymmetry and subsequent erythrocyte 2 þ 5,6 cation channels. death through increased Ca leakage into the cell. Accordingly, erythrocyte death induced by oxidative Cell Death and Differentiation (2005) 12, 415–428. À doi:10.1038/sj.cdd.4401561 stress, energy depletion or removal of external Cl was abrogated and hyperosmotic shock-induced erythrocyte Published online 4 March 2005 death was blunted when the cells are suspended in medium with low free Ca2 þ concentrations.5,6 The signalling pathways Keywords: cell volume; annexin; osmotic cell shrinkage; glu- leading to the activation of the cation channels remained, cose depletion; calcium however, elusive. Subnanomolar concentrations of prostaglandin E2 (PGE2) 22 Abbreviations: PGE2, prostaglandin E2; PS, phosphatidylser- reportedly lead to activation of erythrocyte cation channels, ine; FACS, fluorescence activated cell sorting; t-BHP, t-butylhy- increase in cytosolic Ca2 þ concentration,23 Gardos K þ droxyperoxide; PLA2, phospholipase A2; COX, cyclooxygenase; channel activation, erythrocyte shrinkage and increased PACOCF3, palmitoyltrifluoromethyl ketone; AACOCF3, arachi- erythrocyte filterability.24,25 Thus, the present experiments donyltrifluoromethyl ketone; NMDG, N-methyl-D-glucamine; have been performed to explore the involvement of phospho- EIPA, ethylisopropylamiloride; MAP kinases, mitogen-activated lipase A2 (PLA2) and cyclooxygenase (COX) in the mecha- protein kinase; HEPES, 32-N-2-hydroethylpiperazine-N-2-etha- nisms linking osmotic cell shrinkage, removal of ClÀ, and nesulfonic acid; EGTA, ethylene glycol-bis (b-aminoethyl energy depletion to the activation of the cation channels. It is ether)-N,N,N0,N0-tetraacetic acid; EDTA, ethylenediamine - anticipated that this signalling may be important for properties N,N,N0,N0-tetraacetic acid; DMSO, dimethyl sulfoxide; PBS, and survival of circulating erythrocytes. Erythrocyte cation channel activation PA Lang et al 416 Results acetylsalicylic acid (50 mM; Figure 2e) and diclofenac (10 mM; Figure 2f). Moreover, palmitoyltrifluoromethyl ketone (PA- As disclosed by FACS analysis, some 10% of the erythrocytes COCF3; 4 mM), an inhibitor of the Ca2 þ -independent PLA ,27 7 2 (13 2%; n ¼ 8) incubated in isotonic NaCl Ringer exhibited blocked about 50% of the ClÀ removal-triggered annexin reduced wheat germ lectin (agglutinin) binding (Figure 1a, b) binding (Figure 2g), while arachidonyltrifluoromethyl ketone as a measure of progressive erythrocyte aging.26 Among (AACOCF3; 8 mM), an inhibitor of the cytosolic PLA2, had no those cells, a significantly higher percentage of erythrocytes effect (percentages of annexin-binding cells under control and bound annexin (3.570.5%; n ¼ 8) as compared to (younger) ClÀ-free conditions were 871 and 3177% in the presence of cells with high lectin binding (1.370.2%; n ¼ 8; Figure 1c–e). AACOCF3 and 672 and 3076% in its absence, respectively; These data point to the presence of distinct erythrocyte means7S.E., n ¼ 4). Higher concentrations of AACOCF3 subpopulations which differ in their susceptibility to pro- themselves induced annexin binding of human erythrocytes grammed cell death. An increase of extracellular osmolarity to (data not shown). 850 mOsm by addition of 550 mM sucrose to NaCl Ringer was Similar to its effect on phosphatidylserine exposure upon followed by a sharp increase of the percentage of annexin- hyperosmotic shock or ClÀ removal, quinacrine (25 mM) binding erythrocytes (Figure 2a, left and middle and blunted the annexin binding induced by energy depletion Figure 2b). This increase was significantly blunted in the (Figure 2h). In sharp contrast, ionomycin (1 mM)-triggered presence of the non-specific PLA2 inhibitor quinacrine (25 mM; annexin binding was not sensitive to quinacrine (25 mM; Figure 2a, right, and Figure 2b). The inhibitory effect of Figure 2i). Taken together, the experimental evidence quinacrine on hyperosmotic shock-induced annexin binding strongly suggests the involvement of Ca2 þ -independent was reversed following coincubation with arachidonic acid PLA2 and COX in programmed erythrocyte death triggered (1 mM, Figure 2c). Addition of arachidonic acid (1 mM) alone by osmotic shock or ClÀ removal. did not induce significant annexin binding in isotonic extra- Both experimental manoeuvres, hyperosmotic shock and À cellular fluid (Figure 2c) and did not significantly enhance the Cl removal, indeed stimulated erythrocyte PGE2 release as increase of annexin binding following hyperosmotic shock assessed by competitive ELISA. Hypertonic shock (Figure 3a) À (Figure 2c), suggesting that hyperosmotic shock interferes or Cl -removal (Figure 3b, c) significantly increased the PGE2 with the signalling cascade downstream from PLA2. concentration in the supernatant of erythrocytes within 1 h Replacement of ClÀ by gluconate similarly triggered (850 mOsm) and 3 h (ClÀ-free) of incubation. Under both annexin binding (Figure 2d–g). The percentage of annexin conditions, the PGE2 concentrations in the supernatant binding cells upon 48 h extracellular ClÀ removal was variable remained two- to four-fold enhanced throughout the 6 h of between the individual experiments (5–57% annexin binding) observation (Figure 3a, b). The Ca2 þ ionophore ionomycin À and averaged to 2573% (n ¼ 30). Cl -removal-induced (1 mM for 1 h) did not stimulate erythrocyte PGE2 release annexin binding was again sensitive to quinacrine (25 mM; (Figure 3d). Furthermore, hypertonic shock-stimulated Figure 2d) and inhibited by the cyclooxygenase blockers PGE2 release (850 mOsm for 1 h) was not dependent on a 1000 b 200 e R1 * 4 500 100 13.00 cell counts side sca tter 3 0 0 0 500 1000 100 101 102 103 104 2 forward scatter FL1-H c 4 10 d 4 lectin-FITC+ lectin-FITC 10 1 3 annexinV-Alexa 10 3 10 annexin-binding cells [%] 0.00 0.05 0.34 0.45 0 102 102 FL3-H FL3-H 101 101 positive 15.90 84.05 12.66 86.55 negative 100
Recommended publications
  • Simultaneous Determination of PUFA-Derived Pro-Resolving Metabolites and Pathway Markers Using Chiral Chromatography and Tandem
    Simultaneous determination of PUFA-derived pro-resolving metabolites and pathway markers using chiral chromatography and tandem mass spectrometry Andy Toewe, Laurence Balas, Thierry Durand, Gerd Geisslinger, Nerea Ferreirós To cite this version: Andy Toewe, Laurence Balas, Thierry Durand, Gerd Geisslinger, Nerea Ferreirós. Simultaneous determination of PUFA-derived pro-resolving metabolites and pathway markers using chiral chro- matography and tandem mass spectrometry. Analytica Chimica Acta, Elsevier Masson, 2018, 1031, pp.185-194. 10.1016/j.aca.2018.05.020. hal-02405326 HAL Id: hal-02405326 https://hal.archives-ouvertes.fr/hal-02405326 Submitted on 11 Dec 2019 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Simultaneous determination of PUFA-derived pro-resolving metabolites and pathway markers using chiral chromatography and tandem mass spectrometry a b b a, c a, * Andy Toewe , Laurence Balas , Thierry Durand , Gerd Geisslinger , Nerea Ferreiros a pharmazentrum frankfurt/ZAFES, Institute of Clinical Pharmacology, Goethe-University Frankfurt, Germany b Institut des Biomolecules Max Mousseron, IBMM, UMR 5247, University of Montpellier, CNRS, ENSCM, Montepellier, France c Fraunhofer Institute for Molecular Biology and Applied Ecology IME, Project Group TMP, Frankfurt, Germany abstract Lipid mediators play an important role as biological messengers involved in inflammatory processes.
    [Show full text]
  • Antioxidants and Second Messengers of Free Radicals
    antioxidants Antioxidants and Second Messengers of Free Radicals Edited by Neven Zarkovic Printed Edition of the Special Issue Published in Antioxidants www.mdpi.com/journal/antioxidants Antioxidants and Second Messengers of Free Radicals Antioxidants and Second Messengers of Free Radicals Special Issue Editor Neven Zarkovic MDPI • Basel • Beijing • Wuhan • Barcelona • Belgrade Special Issue Editor Neven Zarkovic Rudjer Boskovic Institute Croatia Editorial Office MDPI St. Alban-Anlage 66 4052 Basel, Switzerland This is a reprint of articles from the Special Issue published online in the open access journal Antioxidants (ISSN 2076-3921) from 2018 (available at: https://www.mdpi.com/journal/ antioxidants/special issues/second messengers free radicals) For citation purposes, cite each article independently as indicated on the article page online and as indicated below: LastName, A.A.; LastName, B.B.; LastName, C.C. Article Title. Journal Name Year, Article Number, Page Range. ISBN 978-3-03897-533-5 (Pbk) ISBN 978-3-03897-534-2 (PDF) c 2019 by the authors. Articles in this book are Open Access and distributed under the Creative Commons Attribution (CC BY) license, which allows users to download, copy and build upon published articles, as long as the author and publisher are properly credited, which ensures maximum dissemination and a wider impact of our publications. The book as a whole is distributed by MDPI under the terms and conditions of the Creative Commons license CC BY-NC-ND. Contents About the Special Issue Editor ...................................... vii Preface to ”Antioxidants and Second Messengers of Free Radicals” ................ ix Neven Zarkovic Antioxidants and Second Messengers of Free Radicals Reprinted from: Antioxidants 2018, 7, 158, doi:10.3390/antiox7110158 ...............
    [Show full text]
  • Effect of Prostanoids on Human Platelet Function: an Overview
    International Journal of Molecular Sciences Review Effect of Prostanoids on Human Platelet Function: An Overview Steffen Braune, Jan-Heiner Küpper and Friedrich Jung * Institute of Biotechnology, Molecular Cell Biology, Brandenburg University of Technology, 01968 Senftenberg, Germany; steff[email protected] (S.B.); [email protected] (J.-H.K.) * Correspondence: [email protected] Received: 23 October 2020; Accepted: 23 November 2020; Published: 27 November 2020 Abstract: Prostanoids are bioactive lipid mediators and take part in many physiological and pathophysiological processes in practically every organ, tissue and cell, including the vascular, renal, gastrointestinal and reproductive systems. In this review, we focus on their influence on platelets, which are key elements in thrombosis and hemostasis. The function of platelets is influenced by mediators in the blood and the vascular wall. Activated platelets aggregate and release bioactive substances, thereby activating further neighbored platelets, which finally can lead to the formation of thrombi. Prostanoids regulate the function of blood platelets by both activating or inhibiting and so are involved in hemostasis. Each prostanoid has a unique activity profile and, thus, a specific profile of action. This article reviews the effects of the following prostanoids: prostaglandin-D2 (PGD2), prostaglandin-E1, -E2 and E3 (PGE1, PGE2, PGE3), prostaglandin F2α (PGF2α), prostacyclin (PGI2) and thromboxane-A2 (TXA2) on platelet activation and aggregation via their respective receptors. Keywords: prostacyclin; thromboxane; prostaglandin; platelets 1. Introduction Hemostasis is a complex process that requires the interplay of multiple physiological pathways. Cellular and molecular mechanisms interact to stop bleedings of injured blood vessels or to seal denuded sub-endothelium with localized clot formation (Figure1).
    [Show full text]
  • Thromboxane B2 Production by Fetal and Neonatal Platelets: Effect of Idiopathic Respiratory Distress Syndrome and Birth Asphyxia
    756 KAAPA ET AL. 0031-3998/84/1808-0756$02.00/0 PEOIATRIC RESEARCH Vol. 18, No.8, 1984 Copyright © 1984 International Pediatric Research Foundation, Inc. Printed in U.S.A. Thromboxane B2 Production by Fetal and Neonatal Platelets: Effect of Idiopathic Respiratory Distress Syndrome and Birth Asphyxia 24 PEKKA KAAPA/ ) LASSE VIINIKKA, AND OLAVI YLIKORKALA Departments ofPediatrics and ClinicalChemistry, University ofOulu, Oulu, and Department ofObstetric and Gynecology, University of Helsinki, Helsinki, Finland Summary asphyxia and IRDS, deficient platelet function may be clinically significant, since these conditions are frequently accompanied To study the production of proaggregatory thromboxane A1 by a hemorrhagic tendency (6). (TxA1) by fetal and neonatal platelets, blood specimens were TxA2, the main derivative ofarach idonic acid in the platelets collected from umbilical cords immediately after delivery at term is the most potent endogenous proaggregatory agent which also (n = 22), from newborn infants during the first 10 days of life (n causes vasoconstriction (5). It is produced and released during = 85), from infants between 1 and 3 months of age (n = 14), and platelet aggregation and rapidly converted to its stable metabolite from healthy adults (n = 18). The blood samples were allowed TxB (4,5). Although the significance ofTxA in adults has been to clot spontaneously at +37°C for 60 min, and the concentrations 2 2 exhaustively studied (4), little is known about TxA2 in the human of thromboxane B2 (TxB1), a stable metabolite of TxA1, in the fetus and neonate although birth causes profound adaptations in sera were measured by radioimmunoassay and expressed as 6 platelet vascular functions (3).
    [Show full text]
  • Differences in Thromboxane Production Between Neonatal and Adult Platelets in Response to Arachidonic Acid and Epinephrine
    NEONATAL PLATELET THROMBOXANE FORMATION 823 003 1-3998/84/1809-0823$02.00/0 PEDIATRIC RESEARCH Vol. 18, No. 9, 1984 Copyright O 1984 International Pediatric Research Foundation, Inc. Prinred in (I.S. A. Differences in Thromboxane Production between Neonatal and Adult Platelets in Response to Arachidonic Acid and Epinephrine MARIE J. STUART, JON DUSSE, DAVID A. CLARK AND RONALD W. WALENGA Divisions of Pediatric Hematology-Oncology and Neonatology, Department of Pediatrics, State University of New York, Upstate Medical Center, Syracuse, New York 13210 Summary An impairment in platelet function is well recognized in the neonate, and includes abnormalities in the release of storage pool In this study, we have investigated the possible role of the pro- adenine nucleotides, and aggregation responses to a variety of aggregatory arachidonic acid (AA) metabolite thromboxane, in stimuli (2, 3, 10). A previous evaluation of exogenous [I4C]AA the impaired function of neonatal platelets. In platelet-rich metabolism in the platelet of the neonate did not suggest that plasma thromboxane production (measured by radioimmunoas- neonatal platelet dysfunction is related to any specific abnor- say of thromboxane B2) was not different between neonates and mality in this pathway (1 3). We observed an increased release of adults when stimulated by thrombin (at 0.1 or 1.0 U/ml) or endogenous AA from neonatal platelet membrane phospholip- collagen (70 pg/ml) although neonatal platelets produced de- ids, and decreased activity of neonatal platelet cyclooxygenase. creased thromboxane (TBXZ) postepinephrine stimulation. In These two effects counteracted each other resulting in similar response to 1 U/ml thrombin, adult and neonatal platelet-rich conversion of prelabeled arachidonic acid to TXBz in adult and plasmas produced mean values of 3.41 + 0.35 (SEM) and 3.11 f 0.49 pmol of TXB2/106 platelets, respectively.
    [Show full text]
  • Cytokines, Angiogenic, and Antiangiogenic Factors and Bioactive Lipids in Preeclampsia
    Nutrition 31 (2015) 1083–1095 Contents lists available at ScienceDirect Nutrition journal homepage: www.nutritionjrnl.com Review Cytokines, angiogenic, and antiangiogenic factors and bioactive lipids in preeclampsia Undurti N. Das M.D., F.A.M.S., F.R.S.C. * UND Life Sciences, Federal Way, WA 98003, USA and Department of Medicine, GVP Hospital and BioScience Research Centre, Campus of Gayatri Vidya Parishad College of Engineering, Visakhapatnam, India article info abstract Article history: Preeclampsia is a low-grade systemic inflammatory condition in which oxidative stress and Received 21 October 2014 endothelial dysfunction occurs. Plasma levels of soluble receptor for vascular endothelial growth Accepted 19 March 2015 factor (VEGFR)-1, also known as sFlt1 (soluble fms-like tyrosine kinase 1), an antiangiogenic factor have been reported to be elevated in preeclampsia. It was reported that pregnant mice deficient in Keywords: catechol-O-methyltransferase (COMT) activity show a preeclampsia-like phenotype due to a Preeclampsia deficiency or absence of 2-methoxyoestradiol (2-ME), a natural metabolite of estradiol that is Lipoxins elevated during the third trimester of normal human pregnancy. Additionally, autoantibodies (AT1- Oxidative stress 2-Methoxyestradiol AAs) that bind and activate the angiotensin II receptor type 1 a (AT1 receptor) also have a role in Polyunsaturated fatty acids preeclampsia. None of these abnormalities are consistently seen in all the patients with pre- Vascular endothelial growth factor eclampsia and some of them are not specific to pregnancy. Preeclampsia could occur due to an Endoglin imbalance between pro- and antiangiogenic factors. VEGF, an angiogenic factor, is necessary for the Soluble fms-like tyrosine kinase 1 transport of polyunsaturated fatty acids (PUFAs) to endothelial cells.
    [Show full text]
  • Increased Prostacyclin and Thromboxane A2 Biosynthesis in Atherosclerosis (Arachidonic Acid) JAWAHAR L
    Proc. Nati. Acad. Sci. USA Vol. 85, pp. 4511-4515, June 1988 Medical Sciences Increased prostacyclin and thromboxane A2 biosynthesis in atherosclerosis (arachidonic acid) JAWAHAR L. MEHTA*t, DANIEL LAWSON*, PAULETTE MEHTA*, AND TOM SALDEENt *University of Florida, College of Medicine and the Veterans Administration Medical Center, Gainesville, FL 32610; and tUniversity of Uppsala, 751 21 Uppsala, Sweden Communicated by George K. Davis, March 2, 1988 ABSTRACT It has been proposed that atherosclerotic PGI2 metabolite released in the urine of patients with severe arteries produce less prostacyclin (PGI2) than nonatheroscle- atherosclerosis, and they demonstrated increased PGI2 bio- rotic arteries do, thereby predisposing arteries to vasospasm synthesis in these patients relative to normal subjects. and thrombosis in vivo. We reexamined this concept by Since many previous studies employed bioassay or only measuring spontaneous as well as arachidonate-induced PGI2 radioimmunoassay (RIA) for measurement of PGI2, the biosynthesis in aortic segments from nonatherosclerotic and present studies were designed to reexamine the concept of cholesterol-fed atherosclerotic New Zealand White rabbits. altered PGI2 generation in atherosclerosis. We examined the Thromboxane A2 (TXA2) generation was also measured. For- uptake and incorporation of labeled arachidonic acid into the mation of PGI2, as well as TXA2, as measured by radio- phospholipids ofthe vessel wall and subsequent arachidonate immunoassay (RIA) of their metabolites, was increased in release and conversion to major metabolites of and atherosclerotic aortic segments relative to nonatherosclerotic PGI2 segments (P S 0.05) at 0, 5, 10, 15, and 30 min of incubation TXA2 in both normal and atherosclerotic vessels. with arachidonate. Pretreatment of arterial segments with indomethacin inhibited PGI2 as well as TXA2 formation, MATERIALS AND METHODS whereas pretreatment with the selective TXA2 inhibitor OKY- 046 inhibited only TXA2 release, thus confirming the identity Induction of Atherosclerosis.
    [Show full text]
  • Lipoxins A4 and B4
    Proc. Nati. Acad. Sci. USA Vol. 85, pp. 8340-8344, November 1988 Physiological Sciences Lipoxins A4 and B4: Comparison of icosanoids having bronchoconstrictor and vasodilator actions but lacking platelet aggregatory activity (pulmonary parenchymal strips/vascular smooth muscle/platelet-rich plasma/leukotriene receptors/thromboxane B2) ALLAN M. LEFER*, GREGORY L. STAHL*, DAVID J. LEFER*, MARK E. BREZINSKI*, K. C. NICOLAOUt, C. A. VEALEt, Y. ABEt, AND J. BRYAN SMITH: *Department of Physiology, Jefferson Medical College, Thomas Jefferson University, Philadelphia, PA 19107; tDepartment of Chemistry, University of Pennsylvania, Philadelphia, PA 19104; and tDepartment of Pharmacology, Temple University School of Medicine, Philadelphia, PA 19140 Communicated by Robert E. Forster, July 28, 1988 (received for review February 1, 1988) ABSTRACT Lipoxins A4 (LxA4) and B4 (LxB4), two activated protein kinase C in vitro and therefore may serve as lipoxygenase-generated icosanoids of arachidonic acid metab- an activator ofintracellular events in smooth muscle cells (6). olism, were found to have a distinct biological profile. Both Secondly, LxA4 has been shown to induce leukocyte lyso- LxA4 and LxB4 slowly contracted pulmonary parenchymal somal membrane leakiness and to release lysosomal hydro- strips isolated from guinea pigs, rabbits, and rats in a concen- lases and superoxide free radicals (7). Immunologically, tration-dependent manner over the range 0.1-1 IAM. This LxA4 and LxB4 block the action of natural killer cells against bronchoconstrictor effect was not associated with release of certain target cells (7). peptide leukotrienes or thromboxane A2, nor was it blocked by More recently, LxA4 has been shown to contract pulmo- lipoxygenase inhibitors or thromboxane receptor antagonists, nary smooth muscle (i.e., guinea pig lung) and to relax suggesting it is a direct effect of lipoxins.
    [Show full text]
  • Thromboxane B2 Assay Parameter
    ParameterTM Thromboxane B2 Assay Catalog Number KGE011 For the quantitative determination of Thromboxane B2 (TXB2) concentrations in cell culture supernates, serum, plasma, and urine. This package insert must be read in its entirety before using this product. For research use only. Not for use in diagnostic procedures. TABLE OF CONTENTS SECTION PAGE INTRODUCTION ....................................................................................................................................................................1 PRINCIPLE OF THE ASSAY ..................................................................................................................................................2 LIMITATIONS OF THE PROCEDURE ................................................................................................................................2 TECHNICAL HINTS ................................................................................................................................................................2 MATERIALS PROVIDED & STORAGE CONDITIONS ..................................................................................................3 OTHER SUPPLIES REQUIRED ............................................................................................................................................3 PRECAUTIONS ........................................................................................................................................................................4 SAMPLE COLLECTION & STORAGE ................................................................................................................................4
    [Show full text]
  • Low Concentrations of Lipid Hydroperoxides Prime Human
    Biochem. J. (1997) 325, 495–500 (Printed in Great Britain) 495 Low concentrations of lipid hydroperoxides prime human platelet aggregation specifically via cyclo-oxygenase activation Catherine CALZADA*, Evelyne VERICEL and Michel LAGARDE INSERM U 352 (affiliated to CNRS), Biochimie et Pharmacologie, INSA-Lyon, Ba# timent 406, 20 Avenue Albert Einstein, 69621 Villeurbanne, France There is mounting evidence that lipid peroxides contribute to than non-eicosanoid peroxides. The priming effect of HPETEs pathophysiological processes and can modulate cellular on platelet aggregation was associated with an increased form- functions. The aim of the present study was to investigate the ation of cyclo-oxygenase metabolites, in particular thromb- effects of lipid hydroperoxides on platelet aggregation and oxane A#, and was abolished by aspirin, suggesting an activation arachidonic acid (AA) metabolism. Human platelets, isolated of cyclo-oxygenase by HPETEs. It was not receptor-mediated from plasma, were incubated with subthreshold (i.e. non- because the 12-HPETE-induced enhancement of AA metabolism aggregating) concentrations of AA in the absence or presence of was sustained in the presence of SQ29,548 or RGDS, which hydroperoxyeicosatetraenoic acids (HPETEs). Although blocked the aggregation. These results indicate that physio- HPETEs alone had no effect on platelet function, HPETEs logically relevant concentrations of HPETEs potentiate platelet induced the aggregation of platelets co-incubated with non- aggregation, which appears to be mediated via a stimulation of aggregating concentrations of AA, HPETEs being more potent cyclo-oxygenase activity. INTRODUCTION not well characterized. Most studies performed in platelets incubated with relatively high concentrations of hydroperoxides Blood platelets have a vital role in haemostatic processes and in have reported an inhibitory effect of these hydroperoxides on pathological events such as complications of thrombosis and platelet aggregation [10,11] but no data to our knowledge have atherosclerosis [1].
    [Show full text]
  • Thromboxane Synthase Is Preferentially Conserved in Activated Mouse Peritoneal Macrophages Catherine S
    Rapid Publication Thromboxane Synthase Is Preferentially Conserved in Activated Mouse Peritoneal Macrophages Catherine S. Tripp, Kathleen M. Leahy, and Philip Needleman Department ofPharmacology, Washington University School ofMedicine, St. Louis, Missouri 63110 Abstract production of leukotriene C4 (LTC4) and monohydroxyeico- satetrienoic acids (HETEs) as well as PGE2 and 6-keto-PGF,. Resident macrophages isolated from uninfected animals produce were decreased in C. parvum-elicited macrophages when com- large quantities of arachidonic acid (AA) metabolites. Immu- pared with resident cells. Paradoxically, the quantity of throm- nizing animals with protein antigens or bacteria activates boxane A2 (TxA2), measured as thromboxane B2 (TxB2), was macrophages and causes an 80% reduction in the cyclooxygenase increased in the C. parvum-elicited macrophages. In this report and lipoxygenase metabolites relative to resident cells. Since we have evaluated the AA and prostaglandin H2 (PGH2)- some products have been shown to modulate immune functions, dependent metabolic enzymes in resident and Listeria mono- we examined how the AA metabolic enzyme activities regulate cytogenes-elicited macrophages (Listeria macrophages) to char- the products that are synthesized. We demonstrate that the acterize the preferential conservation of TxA2 production by cyclooxygenase, 5-lipoxygenase, prostacyclin synthase, and macrophages during an immune response. probably prostaglandin (PG) endoperoxide E-isomerase activ- ities were decreased in activated peritoneal
    [Show full text]
  • Synthesis of Prostaglandin E2, Thromboxane B2 and Prostaglandin Catabolism in Gastritis and Gastric Ulcer
    Gut: first published as 10.1136/gut.27.12.1484 on 1 December 1986. Downloaded from Gut, 1986, 27, 1484-1492 Synthesis of prostaglandin E2, thromboxane B2 and prostaglandin catabolism in gastritis and gastric ulcer C J HAWKEY (WITH THE TECHNICAL ASSISTANCE OF N K BHASKAR AND B FILIPOWICZ) From the Department of Therapeutics, University Hospital, Nottingham SUMMARY Because endogenous prostaglandins may protect the gastric mucosa a study was conducted to determine factors influencing (a) the synthesis of immunoreactive prostaglandin (iPG) E2 and thromboxane (iTx) B2 as measured by radioimmunoassay and (b) prostaglandin catabolism measured radiometrically, in human gastric mucosa. Gastric mucosa was obtained at endoscopy. Synthesis of iPE2 and iTxB2 was inhibited in vitro by indomethacin; iTxB2 synthesis was also selectively inhibited by the thromboxane synthesis inhibitor dazmegrel. Prostaglandin catabolism was inhibited by carbenoxolone. Multivariate analysis showed that synthesis of iPGE2 from endogenous precursor during homogenisation was decreased in patients on non-steroidal anti-inflammatory drugs. Mucosal inflammation was associated with significantly increased synthesis of iPGE2 and decreased prostaglandin catabolism. There were no differences between the mucosa of patients with or without gastric ulcers, nor between the ulcer rim and mucosa 5 cm away. Age, sex, smoking history, and ingestion of antisecretory drugs appeared to exert no influence. In this study gastritis was the major influence on prostaglandin synthesis. It seems unlikely that prostaglandin deficiency is a strong predisposing factor for gastric ulceration. http://gut.bmj.com/ Reports suggesting gastric mucosal protection by ment of thromboxane synthesis as thromboxane endogenous prostaglandin synthesis'-3 raise the synthesis is associated with gastric ulceration in rats possibility that this process might be defective in and inhibitors of thromboxane synthesis appear to patients who develop gastric ulcers.
    [Show full text]